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Abstract 
Background: The emergence of antimicrobial-resistant pathogens associated with hospital-acquired infections 
(HAIs) is a major public health problem worldwide. Although being drug resistance is common in some 
countries and rare in others, the extent of this condition is not precisely known in most parts of Iran. 
Materials and Methods: Clinical specimens from patients who had been in the hospital for at least 48 hours 
were included in this study. The pattern of antibiotic resistance was determined by disk diffusion method as 
recommended by the Clinical Laboratory and Standards Institute (CLSI). 
Results: Of 11164 patients that were investigated, 369 (3.3%) had nosocomial infections. The most 
frequently isolated organisms from all sites of infections were Acinetobacter species (14.2%), Escherichia 
coli (13.7%) and Pseudomonas aeruginosa (9.9%). Among the Gram-negative bacilli, Acinetobacter spp was 
mostly resistant to ciprofloxacin, ceftriaxon, co-trimoxazole and centamicin, while P. aeruginosa was 
frequently resistant to ampicillin/sulbactam (87%). Imipenem and piperacillin/tazobactam were the most 
active antimicrobials against gram-negative microorganisms whereas vancomycin was the antimicrobial 
agent most consistently active against the Gram-positive cocci. 
Conclusions: This study highlights the importance of antimicrobial-resistant pathogens associated with 
nosocomial infection in Tehran, Iran. Using proper diagnostic criteria as well as administering more effective 
treatment may limit the frequency of drug-resistant bacteria associated with HAIs.  
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Introduction 
Hospital-acquired infections (HAIs) are a major 
public health problem in Iran and an obstacle to 
nosocomial infection control programs. According to 
the latest report that has been released by Ministry of 
Health and Medical Education in Iran, the 
nosocomial infection rate increased from 0.6% in 2007 
to 1.1% in 2010
1
. Moreover, based on the several local 
studies, antimicrobial-resistant bacteria were 
responsible for a significant proportion of nosocomial 
infections in adults and children
2
. These 
microorganisms are even showing rising rates of 
resistance to new expensive antibiotics subsequently 
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considered the treatment of choice. This is due to the 
widespread use of broad-spectrum antibiotics in 
health care settings for empiric treatment of 
infections. The production of β‑ lactamase enzymes, 
decreasing permeability and increasing active efflux 
of the antibiotic are among the most common 
mechanisms of resistance in these pathogens
3
. 
Infections due to these antimicrobial-resistant 
bacteria are mostly associated with increased 
treatment failure, higher mortality, longer hospital 
stays, and higher health care costs
4
. Cases of 
antimicrobial-resistant bacteria are reported mainly 
from developed countries, where proper nosocomial 
infection surveillance programs have been 
established for the identification of HAIs and 
associated bacteria. However, the occurrence of 
these pathogens associated with nosocomial 
infections in many low- and middle-income settings 
like Iran is rarely addressed in literatures. In this 
regards, this study was designed: (1) to determine the 
prevalence of antimicrobial-resistant pathogens 
associated with nosocomial infections and (2) to 
summarize rates of antimicrobial resistance in the 
most common isolated pathogens. 
Methods 
Setting and study populations: This retrospective 
study was performed in one of the referral university 
hospitals in Tehran, Iran. The classical information 
for each patient that was referred to medical and 
surgical wards with intensive care units was 
analyzed. The information recorded for each patient 
included; age, gender, department, date of admission, 
date of surgical operations, predisposing conditions 
(blood pressure, renal failure, diabetes, malignancies, 
immunodeficiency), and factors related to health 
care, including surgery procedures, mechanical 
ventilation, intravascular catheter and urinary 
catheter. According to the Center for Disease Control 
and Prevention (CDC) definitions, all patients 
hospitalized for >48 h were included 
5
. The CDC 
criteria were used to identify nosocomial infections
5
. 
Clinical specimens, including blood, urine, 
wound/tissue, cerebrospinal fluid and respiratory 
specimens were collected from patients in different 
wards of the hospital.  
Bacterial isolation: All specimens were collected at 
the bed site, transferred to the laboratory immediately 
and were inoculated on proper culture media within 
two hours. Only one isolate per patient was included. 
Methods used for confirmation of identification-
included examination of colonial morphology, 
haemolytic characteristics on appropriate agar media, 
Gram stain and rapid identification tests (catalase, 
oxidase, coagulase, bile solubility and spot indole). 
Drug Susceptibility Testing: The isolated bacteria 
were inoculated on Mueller Hinton agar (Mast group 
Ltd, Merseyside, UK) and antimicrobial susceptibility 
testing was performed using disk diffusion method as 
recommended by Clinical and Laboratory Standard 
Institute (CLSI No: M2-A9).  
The antibiotic disks were provided from Mast 
diagnostic group Ltd. The antibiotic panels for each 
group of isolates were selected according to CLSI 
guidelines (No: M100-S16). Quality control was 
assured by concurrent testing with the American Type 
Culture Collection (ATCC) strains including 
Escherichia coli ATCC 25922, Pseudomonas 
aeruginosa ATCC 27853 and Staphylococcus aureus 
ATCC 25923.  
The following antibiotics; ciprofloxacin, ofloxacin, 
erythromycin, oxacillin, gentamicin, co-trimoxazole, 
chloramphenicol, vancomycin, rifampin, imipenem, 
ceftazidime, cefotaxime, ceftriaxon, 
piperacillin/tazobactam, ampicillin/sulbactam and 
amikacin, were used for antimicrobial susceptibility 
testing.  
Statistical Analysis: Statistical analysis was carried 
out using SPSS version 20 (SPSS Inc., Chicago, IL, 
USA). 
Results 
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Prevalence of HAI: During the study period, 11164 
patients (45.4% male and 54.6% female) were 
investigated, of whom 369 (3.3%) had nosocomial 
infections. The high rates of HAIs were observed 
among patients admitted in Bone Marrow Transplant 
units, followed by haematology unit, neonatal 
intensive care units, ICU and general surgery unit. 
The lowest prevalence of HAIs occurred in Neonatal 
care ward (Table 1). Bloodstream infection (BSI) 
was the most common infection (50.4%) among 
reported cases, followed by surgical sites infection 
(SSI, 20.3%), urinary tract infections (UTI, 16.2%) 
and lower respiratory tract infection (LRI, 13 %). 
LRI was the most common nosocomial infection in 
intensive care units, whereas in surgical wards the 
most prevalent HAI type was SSI. In hematology 
ward, the HAI was more heterogeneous but was 
mainly BSI.  
Microbiology data: Microbiological reports were 
available for 343 (93%) of patients with HAIs. The 
most prevalent microorganisms from all sites of 
infection was Acinetobacter species (14.2%), 
followed by E. coli (13.7%), P. aeruginosa (9.9%), 
Staphylococcus aureus (9.0%), Klebsiella  spp. 
(6.1%),  Enterobacter spp. (5.8%), Enterococcus spp. 
(4.3%), Staphylococcus epidermidis (4.0%), Candida 
spp. (3.4%) and coagulase-negative Staphylococci 
(1.7%) (Table 2).  Depending on the site of infection, 
the most frequently isolated pathogens were 
Acinetobacter species for LRI and BSI, E. coli for UTI 
and S. aureus for SSI. 
Drug susceptibility patterns: Acinetobacter spp. and 
P. aeruginosa was the most antibiotic-resistant 
pathogens. According to the susceptibility results, 
imipenem and piperacillin/tazobactam were the most 
active antimicrobials against gram-negative bacilli 
whereas vancomycin was the antimicrobial agent most 
consistently active in vitro against the Gram-positive 
cocci (Table3 and Table4).  
Risk factors associated with HAIs: The prevalence 
of HAIs was higher among females than males (3.3% 
and 3.3%). It increased with age from 1.8% in those 
less than 30 years to 8.3% among patients 70 years old 
or older (Table 5). Patients hospitalized for more than 
20 days had a higher prevalence (16.8%) than those 
with shorter hospital stays. Patients with malignancies 
had a higher prevalence than those without. Prevalence 
was also higher among patients with surgical 
Table 1: Characteristics of patient and hospital-acquired infections (HAIs) Prevalence. 
Wards Patients HAIs 
No. % No. % 
Women's Surgery, Gynecology 
 & Oncology 
1753 15.7 35 2 
Neonatal care  1499 13.4 11 0.7 
Ear, nose, throat 1398 12.5 11 0.7 
Plastic surgery 1115 9.9 26 2.3 
Obstetric 950 8.5 9 0.9 
Endocrinology and Rheumatology 854 7.6 16 1.8 
Pediatrics 819 7.3 7 0.8 
General surgery 742 6.6 27 3.6 
Intensive care 726 6.5 57 7.8 
Thoracic surgery 651 5.8 11 1.6 
Hematology 345 3 104 30 
Neonatal intensive care 270 2.4 37 13.7 
Bone Marrow Transplant 42 0.3 18 42.8 
Total 11164 100 369 3.3 
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operations. Patients hospitalized in ICUs had higher 
prevalence of HAIs than those on other wards.  
Patient characteristics like immunodeficiency, 
mechanical ventilation, intravascular catheter and 
urinary catheter did not associate with HAI. 
Discussion 
The infections due to antimicrobial-
resistant pathogens associated with nosocomial 
infections are becoming an increasing problem in 
many countries in the world. Exposure to these 
bacteria has different microbiological and clinical 
implications, as they are capable of colonizing or 
infecting both immunocompetent and 
immunocompromised individual patients in hospital 
settings
6,7
. Cases of nosocomial pathogens are 
reported mainly from developed countries, where 
proper nosocomial infection surveillance program 
has been established for the identification of HAIs 
and associated bacteria
8-10
. However, the prevalence of 
HAIs and related bacteria in many low- and middle-
income settings like Iran is rarely addressed in 
literatures. Some important reasons for their under-
reporting in this country include the lack of 
communication between physicians and 
microbiologists, lack of standardized or accepted 
criteria to determine HAIs and associated pathogens, 
limited laboratory facilities and overburden of other 
community diseases. The absence of information 
regarding the distributions of HAIs and antimicrobial-
resistant pathogens poses significant challenges for 
hospital infection control strategies. 
According to present study, the prevalence of HAI in 
our hospital was 3.3%. This rate of HAIs was 
relatively higher from those of previous studies. 
During 2009–2010, Assar and others reported that 
3.1% of admitted patients at a teaching hospital had 
nosocomial infection
11
. Moreover, the HAI prevalence 
Table 2: Isolated micro-organisms according to different types of nosocomial infections 














4 (7.0) 8 (11.4) 18(11.4) 19(43.1) 0 49(14.2) 
Escherichia coli 20 (35.0) 14 (20.0) 9 (5.7) 3 (6.8) 1 (6.6) 47 (13.7) 
Pseudomonas 
aeruginosa 
8 (14.0) 9 (12.8) 12 (7.6) 3 (6.8) 2 (13.3) 34 (9.9) 
Staphylococcus 
aureus 
0 (0.0) 22 (31.4) 6 (3.8) 3 (6.8) 0 (0.0) 31 (9.0) 
Klebsiella species 6 (10.5) 1 (1.4) 8 (5.0) 4 (9.0) 2 (13.3) 21 (6.1) 
Enterobacter 
species 
10 (17.5) 1 (1.4) 6 (3.8) 2 (4.5) 1 (6.6) 20 (5.8) 
Enterococcus 
species 
4 (7.0) 3 (4.2) 5 (3.1) 0 (0.0) 3 (20.0) 15 (4.3) 
Staphylococcus 
epidermidis 
1 (1.7) 2 (2.8) 11 (7.0) 0 (0.0) 0 (0.0) 14 (4.0) 
Candida species 2 (3.5) 2 (2.8) 4 (2.5) 1 (2.2) 3 (20.0) 12 (3.4) 
coagulase-negative 
Staphylococci 
0 (0.0) 0 (0.0) 6 (3.8) 0 (0.0) 0 (0.0) 6 (1.7) 
Other organisms 2 (3.5) 8 (11.4) 71 (45.2) 9 (20.4) 4 (26.6) 9 4(27.9) 
Total 57 (100.0) 70 (100.0) 157 (100.0) 44 (100.0) 15 (100.0) 343 (100.0) 
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of 3.3% in our study was also higher than what was 
reported by Iranian Nosocomial Infection 
Department
1
. Many studies and prevention programs 
in Iran focus on the impact of HAIs in the ICU
12
. 
However, our data clearly indicate the importance of 
HAIs in other types of hospital wards i.e. Bone 
Marrow Transplant units and Haematology unit. 
Therefore, one of the policy recommendations 
resulting from this study was to extend the of HAI 
prevention strategies to non-ICU wards. Moreover, 
individual hospitals should use their own observation 
and then use the result in order to decide which 
control measures to select. 
In all wards, BSI was the principal type of infection 
found in this study and accounted for the majority of 
hospital-acquired infections. According to the 
literatures, use of central catheters in hospitalized 
patients has been suggested as important risk factors 
for development of BSI
13
. In this regard, hand-
washing before catheters insertion, use maximal 
barriers during catheter insertion, provide an 
effective antisepsis, choose an appropriate insertion 
site, avoid routine central venous catheters 
replacement and staff training are strongly 
recommended to avoid further occurrence of BSI in 
hospital settings
14
.   
As shown in the Table 2, Gram-negative bacilli were 
the most isolated pathogens from all clinical 
specimens in different parts of the hospital. Over the 
last decade, Acinetobacter spp. has been known as an 
important nosocomial pathogen that is often multidrug 
resistant and cause life-threatening infections
15
. It 
represents that the first causal agent of nosocomial 
infection in the present study and is the most frequent 
pathogen isolated from the LRI and BSI. Moreover, in 
the current study, Acinetobacter spp. and P. 
aeruginosa were the most antibiotic-resistant 
microorganisms (Table 4). The increased prevalence 
of antimicrobial-resistant pathogens associated with 
nosocomial infections may have several negative 
impacts on hospital and health issues; for example, 
patients infected with these pathogens require 




CIP* ERT OXA GEN COT CHL VAN RIF 
S. aureus 
  
31 40 56 56 30 37 43 17 45 
S. epidermidis 
 




15 37 83 66 0 66 47 22 0 
*Ciprofloxacin, Erythromycin, Oxacillin, Gentamicin, Co-Trimoxazole, Chloramphenicol, Vancomycin, Rifampin. 
 




IPM* CIP  CAZ CEF COT TZP A/S AMK GEN 
Escherichia coli  47 0 38 
 
50 73 76 4 57 13 25 
Pseudomonas 
aeruginosa  
34 20 52 
 




21 0 23 0 
 








49 12 68 15 89 80 24 14 20 70 
*Imipenem, Ciprofloxacin, Ceftazidime,  Ceftriaxon, Co-trimoxazole,  Piperacillin/Tazobactam Ampicillin/Sulbactam, Amikacin, Gentamicin 
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prolonged and expensive chemotherapy, which has 
considerable implications for the individual patient 
and for the health care settings. Furthermore, 
resistance to antimicrobial agents is frequently 
associated with increased risk of treatment failures 
and acquiring new drug resistance. Therefore, active 
infection control committee and appropriate 
antimicrobial therapy will prevent or lower the 
emergence of antimicrobial-resistant pathogens.  
Conclusion 
In conclusions this study highlights the importance of 
antimicrobial-resistant pathogens associated with 
nosocomial infection in Tehran, Iran. Using proper 
diagnostic criteria as well as administering more 
effective treatment may limit the frequency of drug-
resistant bacteria associated with HAIs.     
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Table 5: Patient characteristics and exposure to extrinsic risk factors. 
 
General characteristics No. of 
patients 
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